Table 3.
Paddock | Sampling Period | RR | 95% CI |
---|---|---|---|
1 | Mid-outbreak | 1.07 | 0.86-1.16 |
2 | Mid-outbreak | 1.12 | 0.93-1.18 |
3 | Mid-outbreak | 0.95 | 0.70-1.10 |
4 | Mid-outbreak | 0.89 | 0.64-1.06 |
5 | Mid-outbreak | 1.07 | 0.86-1.16 |
6 | Mid-outbreak | 1.06 | 0.84-1.16 |
7 | Mid-outbreak | 0.93 | 0.68-1.10 |
8 | Mid-outbreak | 0.91 | 0.63-1.09 |
1 | Post-treatment | 0.063 | 0.0047-0.25 |
2 | Post-treatment | 0.24 | 0.079-0.48 |
3 | Post-treatment | 0.18 | 0.047-0.41 |
4 | Post-treatment | 0.83 | 0.57-1.03 |
5 | Post-treatment | 1.00 | 0.76-1.13 |
6 | Post-treatment | 1.12 | 0.93-1.18 |
7 | Post-treatment | 1.18 | 1.08-1.18 |
8 | Post-treatment | 1.18 | 1.06-1.18 |
All Relative Risk (RR) are relative to the mean risk at the mid-outbreak sampling period. Estimates with statistically significant (p < 0.05) p-values shown in bold type. Estimates with marginally significant (p < 0.1) p-value in italics.